Phase One: Particle Maturation
Initially, newly secreted particles enter the circulation as immature VLDL. To fully perform their physiological function, they require assistance from high-density lipoproteins (HDL).
The interaction occurs as follows:
- HDL act as donors of protein components.
- They transfer specific apoproteins—apoE and apoC-II—onto the surface of immature VLDL.
- Immediately following the acquisition of these apoproteins, the structural conformation changes, and the particles officially attain mature status.
Phase Two: Triacylglycerol Hydrolysis
Once VLDL particles mature, active metabolism is triggered to release lipids. The enzyme lipoprotein lipase (LPL) plays the pivotal role here.
This enzyme acts on the mature particle, hydrolyzing the core lipids (triacylglycerols or TAGs). The hydrolysis results in two major events:
- The TAG content within the lipoprotein particle rapidly decreases.
- The resulting breakdown products—fatty acids and glycerol—leave the bloodstream and enter surrounding tissues for energy generation or structural use.
Phase Three: Formation and Catabolism of IDL
As VLDL lose their primary lipid stores, their physicochemical properties change. The particle transforms and transitions into a new class—IDL (intermediate-density lipoproteins).
Metabolism does not stop here. IDL particles continue to be acted upon by enzymes:
- The familiar lipoprotein lipase.
- Hepatic lipase is also recruited.
Under their combined influence, further hydrolysis of the remaining lipids continues. A key feature of this stage's conclusion is the fate of the apoC-II protein. Because the lipid content of the particle drops critically, this protein is no longer needed and returns to HDL, completing its functional cycle.